These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence. González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659 [TBL] [Abstract][Full Text] [Related]
11. Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice. Huang P; Liu-Chen LY; Unterwald EM; Cowan A Neurosci Lett; 2009 Nov; 465(1):66-70. PubMed ID: 19733208 [TBL] [Abstract][Full Text] [Related]
12. Withdrawal from THC during adolescence: sex differences in locomotor activity and anxiety. Harte-Hargrove LC; Dow-Edwards DL Behav Brain Res; 2012 May; 231(1):48-59. PubMed ID: 22421367 [TBL] [Abstract][Full Text] [Related]
13. Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse. Haney M; Hart CL; Vosburg SK; Comer SD; Reed SC; Foltin RW Psychopharmacology (Berl); 2008 Mar; 197(1):157-68. PubMed ID: 18161012 [TBL] [Abstract][Full Text] [Related]
14. Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs. Stewart JL; McMahon LR J Pharmacol Exp Ther; 2010 Jul; 334(1):347-56. PubMed ID: 20375197 [TBL] [Abstract][Full Text] [Related]
16. Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol. Hutcheson DM; Tzavara ET; Smadja C; Valjent E; Roques BP; Hanoune J; Maldonado R Br J Pharmacol; 1998 Dec; 125(7):1567-77. PubMed ID: 9884086 [TBL] [Abstract][Full Text] [Related]
17. Time-course of the effects of chronic delta 9-tetrahydrocannabinol on behaviour, body temperature, brain amines and withdrawal-like behaviour in the rat. Taylor DA; Fennessy MR J Pharm Pharmacol; 1982 Apr; 34(4):240-5. PubMed ID: 6124598 [TBL] [Abstract][Full Text] [Related]
18. An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity. Navarro M; Fernández-Ruiz JJ; de Miguel R; Hernández ML; Cebeira M; Ramos JA Behav Brain Res; 1993 Oct; 57(1):37-46. PubMed ID: 8292253 [TBL] [Abstract][Full Text] [Related]
19. Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice. Schlosburg JE; Carlson BL; Ramesh D; Abdullah RA; Long JZ; Cravatt BF; Lichtman AH AAPS J; 2009 Jun; 11(2):342-52. PubMed ID: 19430909 [TBL] [Abstract][Full Text] [Related]
20. Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum. Bonnet U; Specka M; Stratmann U; Ochwadt R; Scherbaum N Drug Alcohol Depend; 2014 Oct; 143():189-97. PubMed ID: 25127704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]